The overall prevalence of self-reported ever cannabis use for medical purposes was 27%, with similar rates by sex and the highest prevalence in young adults. Prevalence was higher in US legal–recreational states (34%) than US illegal states (23%), US legal–medical only states (25%), and Canada (25%).
Self-reported use to manage symptoms of PTSD or trauma was associated with use for anxiety or depression (r=0.38, p
Self-reported use to manage symptoms of PTSD or trauma was associated with use for anxiety or depression (r=0.38, p